Ying Cui
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology
- Immunology
- Epidemiology
- Topics
- MicroRNA in disease regulation (23 papers)Cancer-related molecular mechanisms research (20 papers)Circular RNAs in diseases (19 papers)
In The Last Decade
Ying Cui
105 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.4k
- Cancer Research 676
- Oncology 227
- Immunology 212
- Epidemiology 201
Countries citing papers authored by Ying Cui
This map shows the geographic impact of Ying Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cui more than expected).
Fields of papers citing papers by Ying Cui
This network shows the impact of papers produced by Ying Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cui. The network helps show where Ying Cui may publish in the future.
Co-authorship network of co-authors of Ying Cui
This figure shows the co-authorship network connecting the top 25 collaborators of Ying Cui. A scholar is included among the top collaborators of Ying Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Cui. Ying Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 22 | |
| 9 | 13 | |
| 10 | 76 | |
| 11 | 39 | |
| 12 | COVID-19 Screening and Triage Using a Unified Approach to the Management of Relevant Healthcare Workers, Procedure and Goals within a Regional Medical Consortium: a Development from Disorderly to Orderly | 1 |
| 13 | 23 | |
| 14 | 55 | |
| 15 | 41 | |
| 16 | Long non-coding RNA UCA1 modulates the glycolysis of cervical cancer cells by miR-493-5p/HK2. | 12 |
| 17 | 24 | |
| 18 | Antidepressant Activities of Extracts from Gynostemma pentaphyllum(Thunb.) Makino | 1 |
| 19 | EXISTENCE AND UNIQUENESS OF SOLUTIONS TO A SEMILINEAR ELLIPTIC SYSTEM | 0 |
| 20 | Proliferation inhibition of TGP on SMMC-7721 Cell in vitro | 1 |
About Ying Cui
Ying Cui is a scholar working on Cancer Research, Molecular Biology and Pharmacology, having authored 110 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (20 papers) and Circular RNAs in diseases (19 papers). The work is most often cited by research in Cancer Research (676 citations), Molecular Biology (1.4k citations) and Biological Psychiatry (42 citations). Ying Cui has collaborated with scholars based in China, Japan and Hong Kong. Frequent co-authors include Chao Ge, Jinjun Li, Taoyang Chen, Hong Li, Hua Tian, Fangyu Zhao, Yongsheng Chang, Fude Fang, Ming Yao and Haiyang Xie. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.